Metabolic fate of menthofuran in rats. Novel oxidative pathways

Madyastha, K. M. ; Raj, C. P. (1992) Metabolic fate of menthofuran in rats. Novel oxidative pathways Drug Metabolism and Disposition, 20 (2). pp. 295-301. ISSN 0090-9556

Full text not available from this repository.

Official URL: http://dmd.aspetjournals.org/content/20/2/295.abst...

Abstract

Metabolic fate of menthofuran (II) in rats was investigated. Menthofuran (II) was administered orally (200 mg/kg of the body weight/day) to rats for 3 days. The following metabolites were isolated from the urine of these animals: p-cresol (VI), 5-methyl-2-cyclohexen-1-one (VII), 3-methylcyclohexanone (VIII), 3-methylcyclohexanol (IX), 4-hydroxy-4-methyl-2-cyclohexen-1-one (V), geranic acid (XI), neronic acid (XII), benzoic acid (XIII), and 2-[2'-keto-4'-methylcyclohexyl]propionic acid (X). Incubation of menthofuran (II) with phenobarbital-induced rat liver microsomes in the presence of NADPH and oxygen resulted in the formation of a metabolite tentatively identified as 2-Z-(2'-keto-4'-methylcyclohexylidene)propanal (III; alpha,beta-unsaturated-gamma-keto-aldehyde). The structure assigned was further supported by trapping this metabolite (III) as a cinnoline derivative. Phenobarbital-induced rat liver microsomes also converted 4-methyl-2-cyclohexenone (IV) to 4-hydroxy-4-methyl-2-cyclohexenone (V) and p-cresol (VI) in the presence of NADPH and oxygen. On the basis of both in vivo and in vitro studies, a possible mechanism for the formation of p-cresol from menthofuran has been proposed.

Item Type:Article
Source:Copyright of this article belongs to American Society for Pharmacology and Experimental Therapeutics.
ID Code:23483
Deposited On:25 Nov 2010 13:15
Last Modified:10 Jun 2011 06:32

Repository Staff Only: item control page